We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Has Adlai Nortye Ltd. Sponsored ADR (ANL) Outpaced Other Medical Stocks This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Adlai Nortye Ltd. Sponsored ADR (ANL - Free Report) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Adlai Nortye Ltd. Sponsored ADR is one of 925 companies in the Medical group. The Medical group currently sits at #9 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Adlai Nortye Ltd. Sponsored ADR is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for ANL's full-year earnings has moved 33.3% higher within the past quarter. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Our latest available data shows that ANL has returned about 590.8% since the start of the calendar year. At the same time, Medical stocks have gained an average of 2.3%. This shows that Adlai Nortye Ltd. Sponsored ADR is outperforming its peers so far this year.
Another stock in the Medical sector, Cardinal Health (CAH - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 9.5%.
Over the past three months, Cardinal Health's consensus EPS estimate for the current year has increased 4.4%. The stock currently has a Zacks Rank #1 (Strong Buy).
Looking more specifically, Adlai Nortye Ltd. Sponsored ADR belongs to the Medical - Biomedical and Genetics industry, a group that includes 447 individual stocks and currently sits at #86 in the Zacks Industry Rank. On average, stocks in this group have gained 9% this year, meaning that ANL is performing better in terms of year-to-date returns.
On the other hand, Cardinal Health belongs to the Medical - Dental Supplies industry. This 15-stock industry is currently ranked #80. The industry has moved +6.6% year to date.
Investors interested in the Medical sector may want to keep a close eye on Adlai Nortye Ltd. Sponsored ADR and Cardinal Health as they attempt to continue their solid performance.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Has Adlai Nortye Ltd. Sponsored ADR (ANL) Outpaced Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Adlai Nortye Ltd. Sponsored ADR (ANL - Free Report) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Adlai Nortye Ltd. Sponsored ADR is one of 925 companies in the Medical group. The Medical group currently sits at #9 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Adlai Nortye Ltd. Sponsored ADR is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for ANL's full-year earnings has moved 33.3% higher within the past quarter. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Our latest available data shows that ANL has returned about 590.8% since the start of the calendar year. At the same time, Medical stocks have gained an average of 2.3%. This shows that Adlai Nortye Ltd. Sponsored ADR is outperforming its peers so far this year.
Another stock in the Medical sector, Cardinal Health (CAH - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 9.5%.
Over the past three months, Cardinal Health's consensus EPS estimate for the current year has increased 4.4%. The stock currently has a Zacks Rank #1 (Strong Buy).
Looking more specifically, Adlai Nortye Ltd. Sponsored ADR belongs to the Medical - Biomedical and Genetics industry, a group that includes 447 individual stocks and currently sits at #86 in the Zacks Industry Rank. On average, stocks in this group have gained 9% this year, meaning that ANL is performing better in terms of year-to-date returns.
On the other hand, Cardinal Health belongs to the Medical - Dental Supplies industry. This 15-stock industry is currently ranked #80. The industry has moved +6.6% year to date.
Investors interested in the Medical sector may want to keep a close eye on Adlai Nortye Ltd. Sponsored ADR and Cardinal Health as they attempt to continue their solid performance.